Ítem
Solo Metadatos
Clinical Course of Asthma of Children Treatedwith Omalizumab: Multicenter Study Colombia
dc.creator | Morales Munera,Olga Lucía | spa |
dc.creator | Pedraza,Angela María | spa |
dc.creator | Niño Serna,Laura Fernanda | spa |
dc.date.accessioned | 2020-08-06T16:24:08Z | |
dc.date.available | 2020-08-06T16:24:08Z | |
dc.date.created | 2016-04 | spa |
dc.description.abstract | Objective: To describe the clinical characteristics of pediatric patients aged6 to 17 years diagnosed with moderate to severe allergic asthma undergoingtreatment with omalizumab (OMB) from January 2007 to February 2014 in6 cities in Colombia. Methods: This retrospective, longitudinal cohort studyincluded 63 children and adolescents. Evaluated outcomes includedsymptoms control, exacerbations frequency, decreased use of asthmacontrol drugs and presence of adverse events before starting treatment andafter 4 and 12 months of OMB use. Results: after 4 and 12 months oftreatment 89% and 96.6% of children under 12 years of age (p ¼ 0.0015) and78% and 91.6% of children over 12 years of age (p ¼ 0.0145) had goodsymptom control, respectively. Furthermore, after 12 months, the number ofexacerbations decreased to 2 (p ¼ 0.00), the frequency of beta2 rescueinhaler use decreased to 0.37 days (p ¼ 0.00), and the use of controller drugsdecreased in 73% of patients, including decreased use of inhaledcorticosteroids in 62%. Only one severe adverse event was reported inone patient. Conclusion: OMB is an effective drug for the clinical control ofmoderate and severe allergic asthma. It reduces asthma symptoms andexacerbations and exhibits good tolerance and few severe adverse event | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1002/ppul.23409 | |
dc.identifier.issn | ISSN: 8755-6863 | |
dc.identifier.issn | EISSN: 1099-0496 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/26486 | |
dc.language.iso | eng | spa |
dc.publisher | Jhon Wiley & Sons | spa |
dc.relation.citationEndPage | s64 | |
dc.relation.citationIssue | No. S42 | |
dc.relation.citationStartPage | s7 | |
dc.relation.citationTitle | Pediatric Pulmonology | |
dc.relation.citationVolume | Vol. 51 | |
dc.relation.ispartof | Pediatric Pulmonology, ISSN: 8755-6863,Vol.51, No.S42 (2016-04); pp.s7-s64 | spa |
dc.relation.ispartof | XI SOLANEP International Congress / XV Cystic Fibrosis Latinamerican Congress / XV Brazilian Congress of Pediatric Pulmonology | spa |
dc.relation.uri | https://onlinelibrary.wiley.com/doi/epdf/10.1002/ppul.23409 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source | Pediatric Pulmonology | spa |
dc.source.instname | instname:Universidad del Rosario | |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | |
dc.subject.keyword | Medical and Health Sciences | spa |
dc.subject.keyword | Paediatrics and Reproductive Medicine | spa |
dc.title | Clinical Course of Asthma of Children Treatedwith Omalizumab: Multicenter Study Colombia | spa |
dc.title.TranslatedTitle | Curso clínico de asma de niños tratados con Omalizumab: estudio multicéntrico Colombia | spa |
dc.type | conferenceObject | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Documento de conferencia | spa |